GeneDx Holdings Corp. (WGS) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 96.84M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 132.55M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 481.49M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $0.00 | $96.84M | (m) | $132.55M | $481.49M | (m) |
| 2026-03-31 | (m) | (m) | $0.00 | $96.73M | (m) | $170.69M | $506.30M | (m) |
| 2025-12-31 | (m) | (m) | $4.54M | $48.18M | (m) | $171.28M | $523.71M | (m) |
| 2025-09-30 | (m) | (m) | $1.23M | $51.58M | (m) | $155.08M | $493.90M | (m) |
| 2025-06-30 | (m) | (m) | $1.22M | $51.68M | (m) | $134.56M | $463.86M | (m) |
| 2025-03-31 | (m) | (m) | $1.22M | $51.79M | (m) | $159.16M | $446.43M | (m) |
| 2024-12-31 | (m) | (m) | $1.21M | $51.91M | (m) | $141.19M | $419.38M | (m) |
| 2024-09-30 | (m) | (m) | $1.21M | $52.03M | (m) | $116.46M | $408.84M | (m) |
| 2024-06-30 | (m) | (m) | $1.10M | $52.16M | (m) | $106.86M | $389.10M | (m) |
| 2024-03-31 | (m) | (m) | $798.00K | $52.29M | (m) | $112.91M | $394.53M | (m) |
| 2023-12-31 | (m) | (m) | $497.00K | $52.69M | (m) | $130.15M | $418.76M | (m) |
| 2023-09-30 | (m) | (m) | $198.00K | $6.05M | (m) | $114.30M | $417.29M | (m) |
| 2023-06-30 | (m) | (m) | $0.00 | $6.25M | (m) | (m) | $476.39M | (m) |
| 2023-03-31 | (m) | (m) | $0.00 | $6.25M | (m) | (m) | $545.29M | (m) |
| 2022-12-31 | (m) | (m) | $4.75M | $6.25M | (m) | (m) | $490.94M | (m) |
| 2022-09-30 | (m) | (m) | $349.00K | $10.65M | (m) | (m) | $828.97M | (m) |
| 2022-06-30 | (m) | (m) | $0.00 | $11.00M | (m) | (m) | $933.28M | (m) |
| 2022-03-31 | (m) | (m) | $0.00 | $11.00M | (m) | (m) | $517.67M | (m) |
| 2021-12-31 | (m) | (m) | $0.00 | $11.00M | (m) | (m) | $554.09M | (m) |
| 2021-09-30 | (m) | (m) | $0.00 | $11.00M | (m) | (m) | $603.36M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $18.03M | (m) | (m) | $175.53M | (m) |
| 2021-03-31 | (m) | (m) | (m) | $18.50M | (m) | (m) | $219.30M | (m) |
| 2020-12-31 | (m) | (m) | (m) | $18.97M | (m) | (m) | $251.64M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |